Libourne - 02 September 2014 - Fermentalg, an industrial biotechnology company that specializes in the production of oils and proteins derived from microalgae, has announced the appointment of world-renowned microalgae expert Dr. Hywel Griffiths (PhD) to the post of VP Research and Development. He will also be a member of the Management and Scientific Committees.
With a degree and PhD in molecular microbiology from the University of Cambridge, Hywel Griffiths was previously Chief Scientific Officer for Photonz Corporation, a New Zealand biotechnology company specializing in the production of EPA from microalgae.
In March 2013, Dr. Griffiths was named "Young Biotechnologist of the Year" at the NZBIO annual awards ceremony.
Dr. Hywel Griffiths said: "I am delighted to be joining a company with a genuine technological leadership in the industrial exploitation of microalgae. The sheer scale of the work already carried out by Fermentalg and its formidable potential has been clear from day one."
Pierre Calleja, Founder and Chairman and CEO of Fermentalg, added: "We are very pleased to welcome Hywel to the Fermentalg team. His intricate knowledge of the world of microalgae and polyunsaturated fatty acids will enable us to reinforce our development potential and consolidate our barriers to entry. His appointment is also confirmation of our capacity to attract young, world-renowned talent."
The technological leader in the production of oils and proteins through the state-of-the-art industrial exploitation of microalgae (bred in a predominantly heterotrophic mixotrophic environment), Fermentalg's integrated platform is the only one of its kind in the world and closely guarded by the regular filing of patents (25 families). Fermentalg is also able to draw upon a Scientific Committee of internally-acclaimed experts chaired by one of the all-time pioneers of microalgae research, Professor Claude Gudin.
Founded in 2009 by Pierre Calleja, Fermentalg is an industrial biotechnology company that specializes in producing sustainable oils and proteins derived from the exceptional properties of microalgae. Its patented technology allows it to target a range of fast-growing global markets, from nutrition and animal feed to cosmetics and health, green chemistry and energy. Fermentalg has already signed its 1st industrial and commercial joint-venture for the production of Omega-3 oils rich in EPA and DHA as well as several other partnerships with leading industrial groups. Fermentalg shares are listed on Euronext in Paris (FR0011271600 - FALG). For more information, visit the Fermentalg website at: www.fermentalg.com.
|Pierre Calleja||Paul Michalet|
|Chairman and CEO||Chief Finance Officer|
|Tel: +33 (0)5 57 25 02 20||Tel: +33 (0)5 57 25 79 76|
|ACTUS finance & communication
Tel: +33 (0)1 53 67 35 79
|ACTUS finance & communication
Tel: +33 (0)1 77 35 04 36
Communiqués au titre de l'obligation d'information permanente :
- Autres communiqués
Communiqué intégral et original au format PDF :
Si le fichier PDF ne s'affiche pas ou pour le télécharger, cliquez ici.
Pour consulter le fichier PDF en intégralité, cliquez ici.
|FERMENTALG||Euronext Paris||2.85 (c)||-3.72%||50 795|